Delisting riskPopularity #3,172
Outlook Therapeutics (OTLK)
Develops and commercializes ophthalmic bevacizumab for wet age-related macular degeneration.
$0.6732
vs last close−0.02 (−3.30%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 16.77% | 20.26M shares | |
|---|---|---|---|
| 78 holders · as of Jun 30, 2026 | |||
| Insiders | 0.81% | 974.9K shares | |
| 6 holders · as of Aug 14, 2026 | |||
| Other | 82.42% | 99.62M shares | |
| remainder | |||
120.86M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Two share counts disagree (120.86M in the company's Sep 23, 2026 report, 187.00M elsewhere); stakes use the report.
13F, as of Jun 30, 2026
78 holders · 20.26M shares · 29 new positions · 51 increased · 7 reduced · 13 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 4.38M | 3.62% | +2.41M | Aug 13, 2026 |
| Perceptive Advisors LLC | 3.14M | 2.60% | +3.14Mnew | Aug 14, 2026 |
| Marshall Wace, LLP | 1.99M | 1.64% | +1.99M | Aug 13, 2026 |
| BlackRock, Inc. | 1.67M | 1.38% | +1.19M | Aug 7, 2026 |
| Jane Street Group, LLC | 1.43M | 1.18% | +1.43M | Aug 14, 2026 |
| Geode Capital Management, LLC | 1.25M | 1.03% | +642.3K | Aug 12, 2026 |
| Susquehanna International Group, LLP | 968.2K | 0.80% | +834.1K | Aug 14, 2026 |
| HRT Financial LP | 784.9K | 0.65% | +717.1K | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Sukhtian Ghiath M.incl. GMS Ventures & Investments | 16.40% | 42.63M | 13D | Aug 14, 2026 |
| CVI Investments, Inc. | 9.90% | 24.71M | 13G | Aug 19, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 14, 2026 | Robert Charles Jahrdirector, officer: Chief Executive Officer | Purchase · 2 lots | 303,030 | $1.05 | 303,030 |
| Aug 12, 2026 | Ghiath M. Sukhtiandirector, 10 percent owner: | Purchase · 2 lots | 5,050,504 | $1.05 | 27,142,572 |
| Aug 14, 2026 | Lawrence A. Kenyondirector, officer: Chief Financial Officer | Purchase · 2 lots | 202,020 | $1.05 | 207,966 |
| Jul 29, 2026 | Faisal Ghiath Sukhtiandirector | Purchase | 95,398 | $1.05 | 220,972 |
| Jun 2, 2026 | Yezan Munther Haddadindirector | Purchase | 29,000 | $0.8326 | 66,167 |
| May 28, 2026 | Ghiath M. Sukhtiandirector, 10 percent owner: | Purchase · 3 lots | 20,569,708 | $0.5855 | 30,663,496 |
| May 26, 2026 | Kurt J. Hilzingerdirector | Purchase | 400,000 | $0.4413 | 423,655 |
| May 26, 2026 | Randy H. Thurmandirector | Purchase | 5,000 | $0.4290 | 5,593 |
| May 26, 2026 | Yezan Munther Haddadindirector | Purchase | 34,000 | $0.4400 | 37,167 |
| May 27, 2026 | Faisal Ghiath Sukhtiandirector | Purchase | 122,174 | $0.4093 | 125,574 |
House and Senate disclosures
Not reported.